Cynosure Lutronic, a global leader in energy-based medical aesthetic devices, announced the launch of Mosaic 3D, a 1550 nanometer Erbium Glass non-ablative fractional resurfacing laser, while marking the sixth month anniversary of its merger.

Mosaic 3D

The Mosaic 3D platform is designed to significantly improve tone and textural concerns for patients by generating superficial and mid-dermal coagulation. Mosaic 3D is a highly versatile stand-alone platform that allows providers to customize patient treatments for maximum effect while managing patient comfort and minimizing down time with integrated air cooling. The Mosaic 3D’s metal rollers and smart IntelliTrak™ system enable rapid, uniform skin coverage, while unique cold compression sapphire tips reduce superficial energy absorption, allowing for deeper coagulation zones. Mosaic 3D is also enabled by 3D Controlled Chaos Technology™, an algorithm that controls the space and depth of each pulse, helping to maximize energy delivery while minimizing the risk of bulk heating¹.

“Patients often seek treatment for multiple skin concerns, and they are looking for optimal outcomes while balancing time, cost, and convenience. The versatility of Mosaic 3D allows the targeting of both superficial and mid-dermal depths, and it can also be safely paired with other energy-based treatments in a single session for synergistic outcomes. The integrated air-cooling system with sapphire stamping tip is an added convenience, making treatment sessions more comfortable for patients,” commented Jordan V. Wang, MD, MBE, MBA, Medical Research Director at Laser & Skin Surgery Center of New York, and Medical Director at Laser & Skin Surgery Center of Pennsylvania².

Six-Month Milestone and Success

Cynosure Lutronic is excited to mark the successful completion of its first six months since merging. During this time, Cynosure Lutronic has fully unified its teams across North America, achieving seamless alignment across sales, customer service, and clinical training. The company remains on target with its goals of providing best-in-class service and an unparalleled portfolio of aesthetic solutions for its customers.

“Our unified teams have demonstrated incredible agility and dedication throughout this transition; the integration has strengthened our ability to provide best-in-class service and expanded product offerings to meet the specific needs of aesthetic practitioners and patients alike,” commented Nadav Tomer, Cynosure Lutronic CEO.

In addition to completing its integration in North America, Cynosure Lutronic celebrated another major milestone with the inaugural Cynosure Lutronic Academy, held in Las Vegas September 12-15. The Academy hosted over 400 customer attendees, bringing together a diverse group of practitioners, sales professionals, and industry experts to discuss the latest trends in aesthetic medicine, clinical best practices, and product innovation.

About Cynosure Lutronic, Inc

With over 30 years of combined innovation and action as the global leader in energy-based devices and superior medical aesthetic treatments, Cynosure Lutronic enables dermatologists, plastic surgeons, medical spas, and other healthcare practitioners to deliver non-invasive and minimally invasive procedures to their patients. Committed to research and development at the forefront of aesthetic technology, Cynosure Lutronic now proudly offers the most extensive portfolio of aesthetic devices in the industry, providing its customers with a more comprehensive range of solutions for skin resurfacing and revitalization, hair removal, vascular lesion treatment, skin toning, and body contouring. Cynosure Lutronic sells its products globally through a direct sales force in the United States, Canada, France, Morocco, Germany, Spain, the United Kingdom, Australia, China, Japan, and Korea, and through international distributors in approximately 130 other countries. For more information, please visit www.CynosureLutronic.com.

About Hahn & Co.

Hahn & Co. is Korea’s largest private equity investment firm operating in Korea. Companies controlled by Hahn & Co. generate revenues over KRW20 trillion (US$15 billion) with assets of KRW34 trillion (US$27 billion) with over 30,000 employees worldwide (www.hcompany.com).

^{1. The MOSAIC 3D Laser System is indicated for use in dermatological procedures requiring the coagulation of soft tissue, as well as for fractional skin resurfacing procedures.}